John E. La Marca

Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers

Sarah T. Diepstraten, John E. La Marca, Savannah Young et al. · Cancer Cell · 2024 · 47 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Lymphoma cells lacking pro-apoptotic BAX are highly resistant to BH3-mimetics targeting pro-survival MCL-1 but retain sensitivity to conventional DNA-damaging drugs

Sarah T. Diepstraten, Savannah Young, John E. La Marca et al. · Cell Death and Differentiation · 2023 · 24 citations · Full text

Medicine, Oncology, Pharmacology +9

<i>Strip</i>and<i>Cka</i>negatively regulate JNK signalling during<i>Drosophila</i>spermatogenesis

John E. La Marca, Sarah T. Diepstraten, Amy Hodge et al. · Development · 2019 · 20 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +15

Rbf Regulates Drosophila Spermatogenesis via Control of Somatic Stem and Progenitor Cell Fate in the Larval Testis

Nicole Dominado, John E. La Marca, Nicole A. Siddall et al. · Stem Cell Reports · 2016 · 18 citations · Full text

Life Sciences, Developmental Biology, Genetics +17

Phosphorylation of<i>Drosophila</i>Brahma on CDK-phosphorylation sites is important for cell cycle regulation and differentiation

Siti Nur Ain Roesley, John E. La Marca, Andrew J. Deans et al. · Cell Cycle · 2018 · 15 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17